Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2020

Feb 28, 2020

31873_dirs_2020-02-28_6708deb1-8058-4f31-8370-7e1efd38ffc0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-02-04

Reporting Person: RAGUSA ROBERT P (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1702101 Indirect

Footnotes

F1: The amount of Common Stock beneficially owned was previously misstated on the Reporting Person's original Form 4.

F2: The Reporting Person is the Senior Vice President, Global Quality and Operations of Illumina, Inc. and has sole voting and dispositive power over the shares held of record by Illumina, Inc. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.